1 septiembre 2015
In recent years, evidence has been building that injectable contraceptive depot medroxyprogesterone acetate (Depo-Provera or DMPA) is associated with an increased risk of HIV infection. Now a study provides a biological explanation for the phenomenon.
http://www.sciencedaily.com/releases/2015/09/150901113422.htm
